不同系统性红斑狼疮分类标准在真实世界风湿免疫科中的表现
在澳大利亚狼疮登记与生物样本库的394例SLE患者和123例其他风湿病对照中,评估ACR 1997、SLICC 2012、EULAR/ACR 2019和SLERPI 2020分类标准的敏感性、特异性和准确性。SLICC 2012或SLERPI 2020敏感性最高,ACR 1997特异性最高,SLICC 2012总体准确性最高达94.4%(95%CI:91.7,97.1%)。早期SLE亚组中SLICC 2012表现相似。
要点
- SLICC 2012或SLERPI 2020敏感性最高,ACR 1997特异性最高。
- SLICC 2012总体准确性最高,为94.4%(95%CI:91.7,97.1%)。
- 澳大利亚狼疮登记与生物样本库将继续使用ACR 1997和/或SLICC 2012作为观察队列入组标准。
核心结论
- 各分类标准的敏感性和特异性略有差异,本队列中SLICC 2012和SLERPI 2020敏感性最高,ACR 1997特异性最高。
- 所有分类标准均可作为帮助临床医生理解SLE表现的良好教学工具。
- 澳大利亚狼疮登记与生物样本库将继续使用ACR 1997和/或SLICC 2012作为观察队列入组标准。
研究设计与样本
- 纳入澳大利亚狼疮登记与生物样本库的SLE患者,并与从其他风湿免疫科门诊招募的对照进行比较。
- 依据ACR 1997、SLICC 2012、EULAR/ACR 2019或系统性红斑狼疮风险概率指数(SLERPI)回顾临床和免疫学特征。
- 对整体队列和早期SLE患者亚组分别评估每套标准的性能。
- 研究纳入394例SLE患者和123例其他风湿病对照患者。
主要发现
- 使用SLICC 2012或SLERPI 2020标准时敏感性最高。
- 使用ACR 1997标准时特异性最高。
- SLICC 2012标准总体准确性最高,为94.4%(95%CI:91.7,97.1%)。
- 在早期SLE患者亚组分析中,SLICC 2012表现同样良好。
关键数值与推荐
- SLICC 2012标准总体准确性最高,为94.4%(95%CI:91.7,97.1%)。
临床怎么用
- 所有分类标准可作为帮助临床医生理解SLE表现的教學工具。
- 澳大利亚狼疮登记与生物样本库将继续使用ACR 1997和/或SLICC 2012作为观察队列入组标准。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: New classification criteria have been proposed to improve classification of systemic lupus erythematosus (SLE). We aimed to evaluate their performance by determining their sensitivity, specificity and accuracy in a real-world rheumatology department. METHODS: SLE patients who were enrolled in the Australian Lupus Registry and Biobank were included and compared with controls recruited from other rheumatology clinics. Clinical and immunological features were reviewed, according to ACR 1997, SLICC 2012, EULAR/ACR 2019, or Systemic Lupus Erythematosus Risk Probability Index (SLERPI). Performance of each set of criteria was evaluated for the overall cohort and in a subgroup of patients with early SLE. RESULTS: The study included 394 SLE and 123 control patients with other rheumatological conditions. Sensitivity was highest using SLICC 2012 or SLERPI 2020 criteria. Specificity was highest using ACR 1997 criteria. The SLICC 2012 criteria had the highest overall accuracy at 94.4% (95% CI: 91.7, 97.1%). In the subgroup analysis of SLE patients with early disease, SLICC 2012 performed similarly well. CONCLUSIONS: The sensitivity and specificity of each set of classification criteria vary slightly, with SLICC 2012 and SLERPI 2020 having the highest sensitivities and the ACR 1997 criteria having the highest specificity in our patient cohort. All classification criteria serve as good instructional aids for clinicians to understand SLE manifestations. For the Australian Lupus Registry and Biobank, we will continue to use the ACR 1997 and/or SLICC 2012 as entry to the observational cohort.
引用
- Tan BCH, Tang I, Bonin J, et al. The performance of different classification criteria for systemic lupus erythematosus in a real-world rheumatology department. Rheumatology (Oxford). 2022. PMID: 35348630. doi:10.1093/rheumatology/keac120
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。